U.S. House · 117th Congress · H.R. 6988
Drug Manufacturing Innovation Act of 2022
To amend the Federal Food, Drug, and Cosmetic Act to authorize a program to support the adoption of, and improve the development of, innovative approaches to pharmaceutical product design and manufacturing, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Mike LevinD-CA-49
- Introduced
- March 8, 2022, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (1)
1 Republican. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- John JoyceR-PA-13